Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Hepatology. 2018 Sep 20;68(6):2230–2238. doi: 10.1002/hep.30094

Figure 1. Annual total health care costs of NAFLD patients compared to matched controls in reference to the date of index (first) NAFLD diagnosis or matching, respectively.

Figure 1

NAFLD MA: NAFLD patients with Medicare Advantage; NAFLD commercial: NAFLD patients with commercial insurance; controls MA: matched controls with Medicare Advantage; controls commercial: matched controls with commercial insurance.